These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34673934)

  • 41. Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APL.
    Zhou X; Chen X; Chen J; Wen L; Zhang Z; Qin YZ; Cao P; Xing H; Mi Y; Wang W; Zhang G; Li J; Wu H; Zhang Z; Zhang J; Su Z; Wang F; Zhang Y; Ma X; Fang J; Wu P; Wang T; Fan G; Zhao Y; Jin D; Zhang X; Ma X; Wu Q; Zhang Z; Wang L; Ma F; Xiao X; Wu C; Sun K; Tang R; Zhang Y; Wu S; Gao R; Zhang L; Zheng H; Zhao Y; Zhu HH; Lu D; Lu P; Chen S; Liu H
    Blood; 2024 Oct; 144(14):1471-1485. PubMed ID: 39046762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.
    Redner RL; Rush EA; Faas S; Rudert WA; Corey SJ
    Blood; 1996 Feb; 87(3):882-6. PubMed ID: 8562957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.
    Welch JS; Klco JM; Varghese N; Nagarajan R; Ley TJ
    Blood; 2011 Feb; 117(8):2460-8. PubMed ID: 21190992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
    Sainty D; Liso V; Cantù-Rajnoldi A; Head D; Mozziconacci MJ; Arnoulet C; Benattar L; Fenu S; Mancini M; Duchayne E; Mahon FX; Gutierrez N; Birg F; Biondi A; Grimwade D; Lafage-Pochitaloff M; Hagemeijer A; Flandrin G; ; ; ;
    Blood; 2000 Aug; 96(4):1287-96. PubMed ID: 10942370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z; Chen SJ; Wang ZY
    C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
    Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
    Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia.
    Mozziconacci MJ; Liberatore C; Grignani F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Leukemia; 1999 Jun; 13(6):862-8. PubMed ID: 10360373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
    Han X; Jin C; Zheng G; Li Y; Wang Y; Zhang E; Zhu H; Cai Z
    Ther Adv Hematol; 2021; 12():2040620720976984. PubMed ID: 33473264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia.
    Dang DN; Morris HD; Feusner JH; Koduru P; Wilson K; Timmons CF; Cavalier M; Luu HS
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e546-8. PubMed ID: 24942021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
    Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
    Catalano A; Dawson MA; Somana K; Opat S; Schwarer A; Campbell LJ; Iland H
    Blood; 2007 Dec; 110(12):4073-6. PubMed ID: 17712046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia.
    Luo H; Zhang S; Li K; Chen XH; Li YC; Sun Y; Liu LF; Yu HY; Zhu HH
    Leuk Res; 2019 Feb; 77():14-16. PubMed ID: 30612054
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.
    Peterson JF; He RR; Nayer H; Cuevo RS; Smadbeck JB; Vasmatzis G; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB
    Cancer Genet; 2019 Sep; 237():51-54. PubMed ID: 31447065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A study on the relationship between morphology and gene heterogeneity in acute promyelocytic leukemia].
    Xiong S; Chen Z; Huang W
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):165-8. PubMed ID: 7648936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
    Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
    Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
    Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
    Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.